(Q30412506)

English

Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age.

scientific article

Statements

Identification of Antigen and Adjuvant Doses Resulting in Optimal Immunogenicity and Antibody Persistence up to One Year After Immunization with a Pandemic A/H1N1 Influenza Vaccine in Children 3 to < 9 Years of Age. (English)
Cynthia Nassim
Shane Christensen
Sandra Holmes
Matthew Hohenboken
Niranjan Kanesa-Thasan
1 February 2012

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit